U.S. approves medtronic device for heart failure
The U.S. Food and Drug Administration approved Medtronic Inc.'s InSync device for U.S. marketing, the first electrical device ever approved for the treatment of congestive heart-failure patients.
The U.S. Food and Drug Administration approved Medtronic Inc.'s InSync device for U.S. marketing, the first electrical device ever approved for the treatment of congestive heart-failure patients.